A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis.

G, Garratty; N, Postoway; J, Schwellenbach; PC, McMahill

doi:10.1046/j.1537-2995.1991.31291142951.x

Public

A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis.

Shared by NobleBlocks on Feb 1, 1991 • 12:00 AM UTC

Authors:

Garratty G

Postoway N

Schwellenbach J

Abstract

Fatal hemolytic anemia developed in a 52-year-old woman who was treated with a cephalosporin, ceftriaxone. The patient's red cells (RBCs) were coated with C3, but no RBC-bound IgG, IgA, or IgM was detected. Her serum contained an antibody that did not react with cephalosporin-coated RBCs but reacted...

Discussions